Transanal Total Mesorectal Excision: Myths and Reality

Overview

Journal World J Clin Oncol

Publisher Baishideng Publishing Group

Specialty Oncology

Date 2016 Oct 26

PMID 27777876

Citations 4

Authors

Nicolas C Buchs

Marta Penna

Alexander L Bloemendaal

Roel Hompes

Affiliations

Soon will be listed here.

Abstract

Transanal total mesorectal excision (TaTME) is a new and promising approach for the treatment of rectal cancer. Whilst the experience is still limited, there are growing evidences that this approach might overcome the limits of standard low anterior resection. TaTME might help to decrease the conversion rate especially in difficult patients, and to improve the pathological results, while preserving the urogenital function. Evaluation of data from large registries and randomized studies should help to draw firmer conclusions. Beyond these technical considerations, the next challenge seems to be clearly the safe introduction of this approach, motivating the development of dedicated courses.

Citing Articles

Anatomical Considerations and Procedure-Specific Aspects Important in Preventing Operative Morbidity during Transanal Total Mesorectal Excision.

Atallah S Clin Colon Rectal Surg. 2020; 33(3):157-167.

PMID: 32351339 PMC: 7188507. DOI: 10.1055/s-0040-1701604.

Improved urethral fluorescence during low rectal surgery: a new dye and a new method.

Barnes T, Volpi D, Cunningham C, Vojnovic B, Hompes R Tech Coloproctol. 2018; 22(2):115-119.

PMID: 29460054 PMC: 5846816. DOI: 10.1007/s10151-018-1757-6.

How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.

Crawford A, Firtell J, Caycedo-Marulanda A J Gastrointest Cancer. 2018; 50(2):260-268.

PMID: 29388060 DOI: 10.1007/s12029-018-0064-9.

Robotic versus laparoscopic rectal resection for sphincter-saving surgery: pathological and short-term outcomes in a single-center analysis of 130 consecutive patients.

Valverde A, Goasguen N, Oberlin O, Svrcek M, Flejou J, Sezeur A Surg Endosc. 2017; 31(10):4085-4091.

PMID: 28271268 DOI: 10.1007/s00464-017-5455-7.

References

Deijen C, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk E, Sietses C . COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2015; 30(8):3210-5. PMC: 4956704. DOI: 10.1007/s00464-015-4615-x. View

Bondeven P, Hagemann-Madsen R, Laurberg S, Ginnerup Pedersen B . Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging. Br J Surg. 2013; 100(10):1357-67. DOI: 10.1002/bjs.9225. View

Penna M, Knol J, Tuynman J, Tekkis P, Mortensen N, Hompes R . Four anastomotic techniques following transanal total mesorectal excision (TaTME). Tech Coloproctol. 2016; 20(3):185-91. PMC: 4757625. DOI: 10.1007/s10151-015-1414-2. View

Buchs N . Robotic technology: Optimizing the outcomes in rectal cancer?. World J Clin Oncol. 2015; 6(3):22-4. PMC: 4462681. DOI: 10.5306/wjco.v6.i3.22. View

Fernandez-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Diaz Del Gobbo G . Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg. 2014; 261(2):221-7. DOI: 10.1097/SLA.0000000000000865. View

Buchs N, Wynn G, Austin R, Penna M, Findlay J, Bloemendaal A . A two-centre experience of transanal total mesorectal excision. Colorectal Dis. 2016; 18(12):1154-1161. DOI: 10.1111/codi.13394. View

Kneist W, Wachter N, Paschold M, Kauff D, Rink A, Lang H . Midterm functional results of taTME with neuromapping for low rectal cancer. Tech Coloproctol. 2015; 20(1):41-9. DOI: 10.1007/s10151-015-1390-6. View

Ito M, Sugito M, Kobayashi A, Nishizawa Y, Tsunoda Y, Saito N . Relationship between multiple numbers of stapler firings during rectal division and anastomotic leakage after laparoscopic rectal resection. Int J Colorectal Dis. 2008; 23(7):703-7. DOI: 10.1007/s00384-008-0470-8. View

Buchs N, Kraus R, Mortensen N, Cunningham C, George B, Jones O . Endoscopically assisted extralevator abdominoperineal excision. Colorectal Dis. 2015; 17(12):O277-80. DOI: 10.1111/codi.13144. View

10.

Tuech J, Karoui M, Lelong B, de Chaisemartin C, Bridoux V, Manceau G . A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg. 2014; 261(2):228-33. DOI: 10.1097/SLA.0000000000000994. View

11.

van Gijn W, Marijnen C, Nagtegaal I, Meershoek-Klein Kranenbarg E, Putter H, Wiggers T . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12(6):575-82. DOI: 10.1016/S1470-2045(11)70097-3. View

12.

Buchs N, Nicholson G, Yeung T, Mortensen N, Cunningham C, Jones O . Transanal rectal resection: an initial experience of 20 cases. Colorectal Dis. 2015; 18(1):45-50. DOI: 10.1111/codi.13227. View

13.

Kang S, Park J, Jeong S, Nam B, Choi H, Kim D . Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010; 11(7):637-45. DOI: 10.1016/S1470-2045(10)70131-5. View

14.

Lacy A, Tasende M, Delgado S, Fernandez-Hevia M, Jimenez M, de Lacy B . Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients. J Am Coll Surg. 2015; 221(2):415-23. DOI: 10.1016/j.jamcollsurg.2015.03.046. View

15.

Burke J, Martin-Perez B, Khan A, Nassif G, de Beche-Adams T, Larach S . Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal Dis. 2016; 18(6):570-7. DOI: 10.1111/codi.13263. View

16.

Stevenson A, Solomon M, Lumley J, Hewett P, Clouston A, Gebski V . Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA. 2015; 314(13):1356-63. DOI: 10.1001/jama.2015.12009. View

17.

Bonjer H, Deijen C, Abis G, Cuesta M, van der Pas M, de Lange-de Klerk E . A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015; 372(14):1324-32. DOI: 10.1056/NEJMoa1414882. View

18.

van der Pas M, Haglind E, Cuesta M, Furst A, Lacy A, Hop W . Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013; 14(3):210-8. DOI: 10.1016/S1470-2045(13)70016-0. View

19.

Fleshman J, Branda M, Sargent D, Boller A, George V, Abbas M . Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015; 314(13):1346-55. PMC: 5140087. DOI: 10.1001/jama.2015.10529. View

20.

Penna M, Hompes R, MacKenzie H, Carter F, Francis N . First international training and assessment consensus workshop on transanal total mesorectal excision (taTME). Tech Coloproctol. 2016; 20(6):343-352. DOI: 10.1007/s10151-016-1454-2. View